Samsung is building Earth's largest drug manufacturing plant (Samsung does a lot)

Hold the (combusting) phone... We spot a trend. Kodak wants to manufacture drug ingredients. Nestlé bought a biotech company. Samsung... is building a $2B drug plant. The massive Korean conglomerate, most famous for Galaxy phones, also has a massive drug-manufacturing arm. Because if you don’t have a drug-related division during a pandemic, what are you even doing?

• Samsung entered the pharma game late, but has aggressively expanded as corona drug manufacturing needs heat up. Now it's working on potential COVID treatments.
• Samsung Biologics' manufacturing orders nearly 3X'd to $1.5B last quarter. “Covid-19 is giving us more opportunity than crisis” — empathetic leader of Samsung Biologics.
• "Super Plant": Not a plant-based burger company. Samsung is building a $2B drug manufacturing plant that'll be the largest in the world when completed in 2022.

Getting AP Bio flashbacks... The award for most complex corporate structure goes to Samsung. Its Biologics biotech division makes meds for some of the world's largest pharma companies — yet it's just one of many stars in Samsung's corporate galaxy.

• Samsung consists of ~80 companies with different stocks traded on the South Korean stock market.
• Samsung covers over a dozen industries including: life insurance, ship building, resorts, fashion, and asset management. Even Bezos can't keep up.